Olimel N9e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9e provides amino acid supplementation for conditions where protein turnover is increased or intake is insufficient.

• Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair.
• Chronic kidney disease: assists in managing protein‑energy wasting.
• Severe malnutrition: contributes to rebuilding lean body mass.
• Inherited metabolic disorders: supplies specific amino acids that may be deficient.
• Critical illness (ICU): supports overall metabolic demand.

• The formulation delivers a balanced profile of essential and non‑essential amino acids that are directly incorporated into cellular protein synthesis pathways. By supplying substrates for the mTOR signaling cascade, it promotes muscle protein accretion and aids in nitrogen balance, while also supporting gluconeogenesis and other metabolic processes essential for recovery and growth.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Abdominal bloating: sensation of fullness or gas.
• Diarrhoea: loose stools, usually transient.
• Metallic taste: altered perception of taste.
• Headache: mild tension‑type headache.
• Mild hyperkalaemia: slight increase in serum potassium.

Serious or Rare Side Effects

• Severe hypersensitivity: rash, itching, swelling, or anaphylaxis.
• Metabolic acidosis: significant pH imbalance in blood.
• Hyperammonaemia: elevated ammonia levels causing neurological symptoms.
• Renal impairment worsening: decline in kidney function beyond baseline.
• Thromboembolic events: rare clot formation in veins or arteries.

When prescribing Olimel N9e, consider patient‑specific factors and monitor relevant clinical parameters.

• Renal function: assess baseline creatinine and eGFR before initiation.
• Hepatic function: evaluate liver enzymes in patients with liver disease.
• Electrolyte balance: monitor serum potassium and sodium levels regularly.
• Nutritional status: ensure the patient has a documented need for amino acid supplementation.
• Concomitant nutrition therapy: coordinate with other enteral or parenteral formulas to avoid excess protein intake.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid preparations can influence the pharmacokinetics of certain drugs and vice versa.

Major Interactions (Avoid)

• Levodopa: reduced absorption may diminish Parkinson's symptom control.
• MAO inhibitors: risk of hypertensive crisis due to increased catecholamine precursors.
• Thyroid hormone replacement: altered absorption leading to sub‑optimal dosing.

Moderate Interactions (Monitor Closely)

• Anticoagulants (warfarin): potential change in INR values.
• Antiepileptic drugs (phenytoin): possible displacement from protein binding sites.
• Antibiotics (tetracyclines): chelation may reduce antibiotic efficacy.